WebA biweekly scientific journal publishing high-quality research in molecular biology and genetics, cancer biology, biochemistry, and related fields WebFeb 1, 2009 · Inhibition of proliferation in cancer cells treated with selenocystine could be the result of induction of apoptosis or cell cycle arrest or a combination of these two modes. Three susceptible cell lines (A375, HepG2 and MCF7) were selected for mechanistic study of anticancer activity of selenocystine.
Cancers Free Full-Text Combinations of ATR, Chk1 and Wee1 ...
WebLung cancer is the leading cause of cancer-related death. In particular, non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases. ... Mechanistically, lutein exerted antitumorigenic effects by inducing DNA damage and subsequently activating the ATR/Chk1/p53 signaling pathway in A549 cells. In vivo, lutein ... WebApr 13, 2024 · This study aimed to investigate the targeting of checkpoint kinase 1 (CHK1), a critical player regulating the G2/M checkpoint, as a promising strategy to potentiate PBT in human triple-negative breast cancer (TNBC) cells. Protons induced cell-cycle arrest at the G2/M checkpoint more readily in response to increased CHK1 activation than X-rays. truffe photos
Inhibition of the checkpoint kinase Chk1 induces DNA ... - Molecular Cancer
WebSep 1, 2024 · AbstractPurpose:. Checkpoint kinase 1 (CHK1) plays a central role in the response to replication stress through modulation of cell-cycle checkpoints and homologous recombination (HR) repair. In BRCA-deficient cancers with de novo or acquired PARP inhibitor resistance, the addition of the CHK1 inhibitor prexasertib to the PARP inhibitor … WebApr 2, 2024 · Although Chk1 is a promising therapeutic target in p53-deficient cancers, we found that Ras–MEK signaling engages Chk1 in a subset of osteosarcoma, ovarian, and breast cancer cells to enable their survival upon DNA damage, irrespective of … WebJun 8, 2024 · The ATR-CHK1 cascade is heavily involved in cell cycle checkpoint control. ATR activates CHK1 which causes the inactivating phosphorylation of both CDC25C and … philip hohenlohe attorney montana